Log In
Print this Print this

Intron A -Rebetol, Intron A plus Virazole

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionIntron A interferon (IFN) alfa-2b and Virazole oral ribavirin
Molecular Target Type I interferon (IFN) receptor
Mechanism of ActionType I interferon (IFN) receptor agonist
Therapeutic ModalityBiologic
Latest Stage of DevelopmentMarketed
Standard IndicationHepatitis C virus (HCV)
Indication DetailsTreat chronic hepatitis C in pediatric patients; Treat hepatitis C relapse after prior interferon alpha treatment
Regulatory Designation U.S. - Orphan Drug (Treat chronic hepatitis C in pediatric patients)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today